Platform technology in novel vaccine development

Emily Event News Leave a Comment

Levent Shih-Jen Liu, Investigator and CEO of the bioproduction plant at the Taiwan National Institute of Infectious Diseases and Vaccinology is a highly experienced researcher working on novel vaccine development technique. Joining us at Phar-East in Singapore, Levent will speak on a core platform technology which their team has developed to help high volume production of recombinant lipoproteins with built-in potentiation …